CX3CL1 and ovarian carcinoma: The results showed that the CX3CL1 genotypes rs223815 (χ2 = 6.592, p = 0.037) and rs682082 (χ2 = 7.025, p = 0.030) were closely related to the clinical efficacy of carboplatin treatment for ovarian cancer.